P. Lykoudis, O. Reilly, D. Nastos, K. Fusai, and G. , Systematic review of surgical management of synchronous colorectal liver metastases, British Journal of Surgery, vol.15, issue.6, pp.605-617, 2014.
DOI : 10.1111/j.1477-2574.2012.00597.x

R. Adam, D. A. Wicherts, R. J. De-haas, O. Ciacio, F. Lévi et al., Patients With Initially Unresectable Colorectal Liver Metastases: Is There a Possibility of Cure?, Journal of Clinical Oncology, vol.27, issue.11, pp.1829-1864, 2009.
DOI : 10.1200/JCO.2008.19.9273

E. Cutsem, A. Van, B. Cervantes, D. Nordlinger, and . Arnold, Metastatic colorectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up, Annals of Oncology, vol.25, issue.suppl 3, pp.1-9, 2014.
DOI : 10.1093/annonc/mdu260

J. S. Wagner, M. A. Adson, J. A. Van-heerden, M. H. Adson, and D. M. Ilstrup, The Natural History of Hepatic Metastases from Colorectal Cancer, Annals of Surgery, vol.199, issue.5, pp.502-510, 1984.
DOI : 10.1097/00000658-198405000-00002

E. Sadot, J. N. Bas-groot-koerkamp, J. Leal, M. Shia, P. J. Gonen et al., Resection Margin and Survival in 2368 Patients Undergoing Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.262, issue.3, pp.476-85, 2015.
DOI : 10.1097/SLA.0000000000001427

A. K. Siriwardena, M. James, S. Mason, H. C. Mullamitha, S. Hancock et al., Management of colorectal cancer presenting with synchronous liver metastases, Nature Reviews Clinical Oncology, vol.52, issue.8, pp.446-59, 2014.
DOI : 10.1634/theoncologist.2012-0121

Y. Maeda, T. Shinohara, A. Nagatsu, N. Futakawa, and T. Hamada, Long-Term Outcomes of Conversion Hepatectomy for Initially Unresectable Colorectal Liver Metastases, Annals of Surgical Oncology, vol.243, issue.29, pp.242-290, 2016.
DOI : 10.1097/01.sla.0000193603.26265.c3

R. Hickey, M. Vouche, D. Y. Sze, E. Hohlastos, J. Collins et al., Cancer Concepts and Principles: Primer for the Interventional Oncologist???Part II, Journal of Vascular and Interventional Radiology, vol.24, issue.8, pp.1167-88, 2013.
DOI : 10.1016/j.jvir.2013.04.023

. Mehrzad, M. Valiollah, M. Roayaei, E. Saleh-peikar, F. Nouranian et al., Bevacizumab plus FOLFOX or FOLFIRI Regimens on Patients with Unresectable Liver-Only Metastases of Metastatic Colorectal Cancer, Advanced Biomedical Research, vol.5, 2016.

R. Lencioni, R. C. Thierry-de-baere, C. W. Martin, G. Nutting, and . Narayanan, Image-Guided Ablation of Malignant Liver Tumors: Recommendations for Clinical Validation of Novel Thermal and Non-Thermal Technologies - A Western Perspective, Liver Cancer, vol.4, issue.4, pp.208-1410, 2015.
DOI : 10.1159/000367747

R. Hickey, R. J. Lewandowski, T. Prudhomme, E. Ehrenwald, B. Baigorri et al., Y90 Radioembolization of Colorectal Hepatic Metastases Using Glass Microspheres: Safety and Survival Outcomes from a 531-Patient Multicenter Study, Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, 2015.

A. Saxena, J. Meteling, S. Kapoor, D. L. Golani, L. Morris et al., Is Yttrium-90 Radioembolization a Viable Treatment Option for Unresectable, Chemorefractory Colorectal Cancer Liver Metastases? A Large Single-Center Experience of 302 Patients, Annals of Surgical Oncology, vol.2011, issue.3
DOI : 10.1371/journal.pone.0069448

D. B. Brown, B. Nikolic, A. M. Covey, C. W. Nutting, E. A. Wael et al., Quality Improvement Guidelines for Transhepatic Arterial Chemoembolization, Embolization, and Chemotherapeutic Infusion for Hepatic Malignancy, Journal of Vascular and Interventional Radiology, vol.23, issue.3, pp.287-94, 2012.
DOI : 10.1016/j.jvir.2011.11.029

G. Fiorentini, C. Aliberti, M. Tilli, L. Mulazzani, F. Graziano et al., Intra-Arterial Infusion of Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) versus Intravenous Therapy (FOLFIRI) for Hepatic Metastases from Colorectal Cancer: Final Results of a Phase III Study, Anticancer Research, vol.32, issue.4, pp.1387-95, 2012.

R. C. Martin, J. Howard, D. Tomalty, K. Robbins, R. Padr et al., Toxicity of Irinotecan-Eluting Beads in the Treatment of Hepatic Malignancies: Results of a Multi-Institutional Registry, CardioVascular and Interventional Radiology, vol.84, issue.5, pp.960-66, 2010.
DOI : 10.1155/2009/539795

G. Fiorentini, C. Aliberti, G. Turrisi, A. D. Conte, S. Rossi et al., Intraarterial Hepatic Chemoembolization of Liver Metastases from Colorectal Cancer Adopting Irinotecan-Eluting Beads: Results of a Phase II Clinical Study, In Vivo, vol.21, issue.6, pp.1085-91, 2007.

G. Fiorentini, C. Aliberti, L. Mulazzani, P. Coschiera, V. Catalano et al., Chemoembolization in Colorectal Liver Metastases: The Rebirth, Anticancer Research, vol.34, issue.2, pp.575-84, 2014.

J. M. Collins, Pharmacologic rationale for regional drug delivery., Journal of Clinical Oncology, vol.2, issue.5, pp.498-504, 1984.
DOI : 10.1200/JCO.1984.2.5.498

A. J. Richardson, M. Jerome, V. W. Laurence, and . Lam, Transarterial Chemoembolization with Irinotecan Beads in the Treatment of Colorectal Liver Metastases: Systematic Review, Journal of Vascular and Interventional Radiology, vol.24, issue.8, pp.1209-1226, 2013.
DOI : 10.1016/j.jvir.2013.05.055

G. Narayanan, K. Barbery, R. Suthar, G. Guerrero, and G. Arora, Transarterial chemoembolization using DEBIRI for treatment of hepatic metastases from colorectal cancer, Journal of Vascular and Interventional Radiology, vol.24, issue.4, pp.2077-83, 2013.
DOI : 10.1016/j.jvir.2013.01.030

K. Eichler, S. Zangos, M. G. Mack, R. Hammerstingl, T. Gruber-rouh et al., First human study in treatment of unresectable liver metastases from colorectal cancer with irinotecan-loaded beads (DEBIRI), International Journal of Oncology, vol.41, issue.4, pp.1213-1233, 2012.
DOI : 10.3892/ijo.2012.1572

M. Stutz, A. Mamo, D. Valenti, A. Hausvater, T. Cabrera et al., Real- Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer, Real-Life Report on Chemoembolization Using DEBIRI for Liver Metastases from Colorectal Cancer, Gastroenterology Research and Practice, vol.10, pp.715102-715112, 1155.

R. C. Martin, R. Charles, M. Scoggins, W. S. Schreeder, C. J. Rilling et al., Randomized controlled trial of irinotecan drug-eluting beads with simultaneous FOLFOX and bevacizumab for patients with unresectable colorectal liver-limited metastasis, Cancer, vol.25, issue.suppl 4, pp.3649-58, 2015.
DOI : 10.1016/j.jvir.2013.11.027

R. Lencioni, C. Aliberti, R. Thierry-de-baere, G. Garcia-monaco, E. O. Narayanan et al., Transarterial Treatment of Colorectal Cancer Liver Metastases with Irinotecan-Loaded Drug-Eluting Beads: Technical Recommendations, Journal of Vascular and Interventional Radiology, vol.25, issue.3, pp.365-69, 2014.
DOI : 10.1016/j.jvir.2013.11.027

M. Borner, Neoadjuvant chemotherapy for unresectable liver metastases of colorectal cancer-too good to be true?, Annals of Oncology, vol.10, issue.6, pp.623-629, 1999.
DOI : 10.1023/A:1008353227103

M. Ducreux, O. Bouche, J. P. Pignon, M. Mousseau, J. L. Raoul et al., Randomised Trial Comparing Three Different Schedules of Infusional 5FU and Raltitrexed Alone as First-Line Therapy in Metastatic Colorectal Cancer, Oncology, vol.15, issue.3, pp.222-252, 2006.
DOI : 10.1016/S0140-6736(00)02034-1

G. Portier, D. Elias, O. Bouche, P. Rougier, J. Bosset et al., Multicenter Randomized Trial of Adjuvant Fluorouracil and Folinic Acid Compared With Surgery Alone After Resection of Colorectal Liver Metastases: FFCD ACHBTH AURC 9002 Trial, Journal of Clinical Oncology, vol.24, issue.31, pp.4976-82, 2006.
DOI : 10.1200/JCO.2006.06.8353

URL : https://hal.archives-ouvertes.fr/hal-00485672

P. Yaffee, A. Osipov, C. Tan, R. Tuli, and A. Hendifar, Review of Systemic Therapies for Locally Advanced and Metastatic Rectal Cancer, Journal of Gastrointestinal Oncology, vol.6, issue.2, 2015.

H. S. Hochster, M. O. Eileen, J. A. Reilly, A. P. Ajani, and . Venook, Section III: Treatment of Advanced Gastrointestinal Cancers, Gastrointestinal Cancer Research, vol.1, issue.6

E. P. Misiakos, P. Nikolaos, G. Karidis, and . Kouraklis, Current treatment for colorectal liver metastases, World Journal of Gastroenterology, vol.17, issue.36, pp.4067-75, 2011.
DOI : 10.3748/wjg.v17.i36.4067

A. Jemal, R. Siegel, E. Ward, T. Murray, J. Xu et al., Cancer Statistics, 2007, CA: A Cancer Journal for Clinicians, vol.57, issue.1, pp.43-66, 2007.
DOI : 10.3322/canjclin.57.1.43

L. L. Gunderson, . John-milburn, D. J. Jessup, F. L. Sargent, A. K. Greene et al., Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data, Journal of Clinical Oncology, vol.28, issue.2, pp.264-71, 2010.
DOI : 10.1200/JCO.2009.24.0952

C. Gospodarowicz and . Wittekind, TNM Classification of Malignant Tumours, 2009.

B. Nordlinger, H. Sorbye, B. Glimelius, G. J. Poston, M. Peter et al., Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial, The Lancet, vol.371, issue.9617, pp.1007-1023, 2008.
DOI : 10.1016/S0140-6736(08)60455-9

P. Therasse, S. G. Arbuck, E. A. Eisenhauer, J. Wanders, R. S. Kaplan et al., New Guidelines to Evaluate the Response to Treatment in Solid Tumors, JNCI: Journal of the National Cancer Institute, vol.92, issue.3, pp.205-221, 2000.
DOI : 10.1093/jnci/92.3.205

L. L. Gunderson, . John-milburn, D. J. Jessup, F. L. Sargent, A. K. Greene et al., Revised TN Categorization for Colon Cancer Based on National Survival Outcomes Data, Journal of Clinical Oncology, vol.28, issue.2, pp.264-71, 2010.
DOI : 10.1200/JCO.2009.24.0952

C. Du-côlon and |. Snfge, org -Société Savante Médicale Française D'hépato-Gastroentérologie et D'oncologie Digestive, 2016.

G. P. Kim and A. Grothey, Targeting Colorectal Cancer with Human Anti-EGFR Monoclonocal Antibodies: Focus on Panitumumab, Biologics : Targets & Therapy, vol.2, issue.2, pp.223-251, 2008.

. Van-cutsem, M. Eric, S. Peeters, Y. Siena, A. Humblet et al., Open-Label Phase III Trial of Panitumumab Plus Best Supportive Care Compared With Best Supportive Care Alone in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.25, issue.13, pp.1658-64, 2007.
DOI : 10.1200/JCO.2006.08.1620

. Rockette, Comparative Efficacy of Adjuvant Chemotherapy in Patients with Dukes' B versus Dukes' C Colon Cancer: Results from Four National Surgical Adjuvant Breast and Bowel Project Adjuvant Studies (C-01, C-02, C-03, and C-04), Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.17, issue.5, pp.1349-55, 1999.

J. Sakamoto, Y. Ohashi, C. Hamada, M. Buyse, T. Burzykowski et al., Meta-Analysis Group of the Japanese Society for Cancer of the Colon and Rectum, and Meta-Analysis Group in Cancer Efficacy of Oral Adjuvant Therapy after Resection of Colorectal Cancer: 5-Year Results from Three Randomized Trials, Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, vol.22, issue.3, pp.484-92, 2004.

S. Gill, Adjuvant therapy for resected high-risk colon cancer: Current standards and controversies, Indian Journal of Medical and Paediatric Oncology, vol.35, issue.3, pp.197-202, 2014.
DOI : 10.4103/0971-5851.142032

A. Figueredo, M. L. Charette, J. Maroun, M. C. Brouwers, and L. Zuraw, Adjuvant Therapy for Stage II Colon Cancer: A Systematic Review From the Cancer Care Ontario Program in Evidence-Based Care???s Gastrointestinal Cancer Disease Site Group, Journal of Clinical Oncology, vol.22, issue.16, pp.3395-3407, 2004.
DOI : 10.1200/JCO.2004.03.087

O. Connor, E. S. David-yu-greenblatt, N. K. Loconte, R. E. Gangnon, J. Liou et al., Adjuvant Chemotherapy for Stage II Colon Cancer With Poor Prognostic Features, Journal of Clinical Oncology, vol.29, issue.25, pp.3381-88, 2011.
DOI : 10.1200/JCO.2010.34.3426

W. Zhou, S. N. Goodman, G. Galizia, E. Lieto, F. Ferraraccio et al., Counting alleles to predict recurrence of early-stage colorectal cancers, The Lancet, vol.359, issue.9302, pp.219-244, 2002.
DOI : 10.1016/S0140-6736(02)07448-2

F. Pagès, A. Kirilovsky, B. Mlecnik, M. Asslaber, M. Tosolini et al., In Situ Cytotoxic and Memory T Cells Predict Outcome in Patients With Early-Stage Colorectal Cancer, Journal of Clinical Oncology, vol.27, issue.35, pp.5944-51106147, 1200.
DOI : 10.1200/JCO.2008.19.6147

M. Buyse and P. Piedbois, Should DUKES'B patients recieve adjuvant therapy ? A statistical perspective, Sem Oncol, vol.1, issue.1, pp.20-24, 2001.

A. Zaniboni, R. Labianca, S. Marsoni, V. Torri, P. Mosconi et al., GIVIO-SITAC 01, Cancer, vol.15, issue.11, pp.2135-2179, 1998.
DOI : 10.1093/jnci/88.15.1039

B. C. Lembersky, H. Samuel-wieand, N. J. Petrelli, M. J. Connell, L. H. Colangelo et al., Oral Uracil and Tegafur Plus Leucovorin Compared With Intravenous Fluorouracil and Leucovorin in Stage II and III Carcinoma of the Colon: Results From National Surgical Adjuvant Breast and Bowel Project Protocol C-06, Journal of Clinical Oncology, vol.24, issue.13, pp.2059-64, 2006.
DOI : 10.1200/JCO.2005.04.7498

G. Francini, R. Petrioli, L. Lorenzini, S. Mancini, S. Armenio et al., Folinic acid and 5-fluorouracil as adjuvant chemotherapy in colon cancer, Gastroenterology, vol.106, issue.4, pp.899-906, 1994.
DOI : 10.1016/0016-5085(94)90748-X

O. Connell, M. J. , J. A. Mailliard, M. J. Kahn, J. S. Macdonald et al., Controlled trial of fluorouracil and low-dose leucovorin given for 6 months as postoperative adjuvant therapy for colon cancer., Journal of Clinical Oncology, vol.15, issue.1, pp.246-50, 1997.
DOI : 10.1200/JCO.1997.15.1.246

Q. Group and . Collaborative, Adjuvant Chemotherapy versus Observation in Patients with Colorectal Cancer: A Randomised Study, The Lancet, vol.370, issue.1507, pp.2020-2049, 2007.

D. G. Haller, J. Paul, J. S. Catalano, M. A. Macdonald, M. S. O-'rourke et al., Phase III Study of Fluorouracil, Leucovorin, and Levamisole in High-Risk Stage II and III Colon Cancer: Final Report of Intergroup 0089, Journal of Clinical Oncology, vol.23, issue.34, pp.8671-78, 2005.
DOI : 10.1200/JCO.2004.00.5686

C. Moertel, T. Fleming, M. Donald, J. Haller, D. Laurie et al., Levamisole and Fluorouracil for Adjuvant Therapy of Resected Colon Carcinoma, New England Journal of Medicine, vol.322, issue.6, pp.352-360, 1990.
DOI : 10.1056/NEJM199002083220602

T. André, C. P. Louvet, C. Gamelin, E. Bouche, O. Achille et al., Semimonthly Versus Monthly Regimen of Fluorouracil and Leucovorin Administered for 24 or 36 Weeks as Adjuvant Therapy in Stage II and III Colon Cancer: Results of a Randomized Trial, Journal of Clinical Oncology, vol.21, issue.15, pp.2896-903, 2003.
DOI : 10.1200/JCO.2003.10.065

T. André, E. Quinaux, C. Louvet, E. Gamelin, O. Bouche et al., Updated results at 6 year of the GERCOR C96.1 phase III study comparing LV5FU2 to monthly 5FU-leucovorin (mFufol) as adjuvant treatment for Dukes B2 and C colon cancer patients (abstr 3576), J Clin Oncol, vol.23, p.251, 2005.

C. Carrato, L. Köhne, I. Bedenne, O. Popov, E. Bouche et al., Folinic acid modulated bolus 5-FU or infusional 5- FU for adjuvant treatment of patients of UICC stage III colon cancer: Preliminary analysis of the PETACC-2-study, J Clin Oncol, vol.24, issue.18S, p.3563, 2006.

C. Twelves, A. Wong, M. P. Nowacki, M. Abt, H. Burris et al., Capecitabine as Adjuvant Treatment for Stage III Colon Cancer, New England Journal of Medicine, vol.352, issue.26, pp.2696-2704, 2005.
DOI : 10.1056/NEJMoa043116

C. Twelves, W. Scheithauer, J. Mckendrick, J. Seitz, G. Van-hazel et al., Capecitabine versus 5-fluorouracil/folinic acid as adjuvant therapy for stage III colon cancer: final results from the X-ACT trial with analysis by age and preliminary evidence of a pharmacodynamic marker of efficacy, Annals of Oncology, vol.23, issue.5, pp.366-376, 2011.
DOI : 10.1093/annonc/mdr366

V. Vilgrain, M. Esvan, M. Ronot, A. Caumont-prim, C. Aubé et al., A meta-analysis of diffusion-weighted and gadoxetic acid-enhanced MR imaging for the detection of liver metastases, European Radiology, vol.25, issue.12, pp.10-1007, 2016.
DOI : 10.1007/s00330-015-3615-5

. Wiering, P. F. Bastiaan, G. J. Krabbe, . Jager, J. G. Wim et al., The impact of fluor-18-deoxyglucose-positron emission tomography in the management of colorectal liver metastases, Cancer, vol.233, issue.12, pp.2658-70, 2005.
DOI : 10.1097/00000658-200103000-00001

S. Bipat, M. S. Van-leeuwen, E. F. Comans, E. J. Milan, P. M. Pijl et al., Colorectal Liver Metastases: CT, MR Imaging, and PET for Diagnosis???Meta-analysis, Radiology, vol.237, issue.1, pp.123-154, 2005.
DOI : 10.1148/radiol.2371042060

T. Ruers, B. Wiering, . Van-de-sijp, R. Toumen, and K. De-jong, Improved Selection of Patients for Hepatic Surgery of Colorectal Liver Metastases with 18F-FDG PET: A Randomized Study, Journal of Nuclear Medicine, vol.50, issue.7, 2009.
DOI : 10.2967/jnumed.109.063040

H. Hochster, L. Hart, R. Ramanathan, B. Cjilds, J. Hainsworth et al., Safety and efficacy of oxaliplatin and fluoropyrimidine regimens with or without bévacizumab as firts-lin treatment of metastatic colorectl cancer : results of the TREE Study, Journal of Clinical Oncology, 2008.

O. Glehen, E. Cotte, V. Schreiber, A. Sayag-beaujard, J. Vignal et al., Intraperitoneal chemohyperthermia and attemped cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origine, Brittish Journal of Surgery, vol.91, pp.747-54, 2004.

R. Guimbaud, Quelle est la place de la chimiothérapie néoadjuvante, adjuvante et palliative dans la prise en charge des métastases hépatiques d'ogigine colorectale ?, Gastroenterol Clin Biol, vol.27, issue.suppl2, pp.63-79, 2003.

G. P. Kanas, A. Taylor, N. John, . Primrose, J. Wendy et al., Survival after Liver Resection in Metastatic Colorectal Cancer: Review and Meta-Analysis of Prognostic Factors, Clinical Epidemiology, vol.4, pp.283-301, 2012.

J. S. Tomlinson, R. William, R. P. Jarnagin, Y. Dematteo, P. Fong et al., Actual 10-Year Survival After Resection of Colorectal Liver Metastases Defines Cure, Journal of Clinical Oncology, vol.25, issue.29, pp.4575-80, 2007.
DOI : 10.1200/JCO.2007.11.0833

K. Ito, A. Govindajaran, . Anand, H. Ito, and Y. Fong, Surgical Treatment of Hepatic Colorectal Metastasis, The Cancer Journal, vol.16, issue.2, 2016.
DOI : 10.1097/PPO.0b013e3181d7e8e5

L. Chiche, Quelles métastases hépatiques sont résécables d'emblée ?, Gastroenterol Clin Biol, vol.27, issue.suppl2, pp.41-62, 2003.

J. Vauthey, T. M. Pawlik, E. K. Abdalla, J. F. Arens, R. A. Nemr et al., Is Extended Hepatectomy for Hepatobiliary Malignancy Justified?, Annals of Surgery, vol.239, issue.5, pp.722-754, 2004.
DOI : 10.1097/01.sla.0000124385.83887.d5

R. Taylor and Y. Fong, Surgical treatment of hepatic metastases from colorectal cancer In: Blumgart LH. Surgery of the liver, biliary tract, and pancreas, pp.1178-1194, 2007.

J. Vauthey, T. M. Pawlik, D. Ribero, T. Wu, D. Zorzi et al., Chemotherapy Regimen Predicts Steatohepatitis and an Increase in 90-Day Mortality After Surgery for Hepatic Colorectal Metastases, Journal of Clinical Oncology, vol.24, issue.13, pp.2065-72, 2006.
DOI : 10.1200/JCO.2005.05.3074

R. Adam, V. Delvart, G. Pascal, A. Valeanu, D. Castaing et al., Rescue Surgery for Unresectable Colorectal Liver Metastases Downstaged by Chemotherapy, Transactions of the ... Meeting of the American Surgical Association, vol.CXXII, issue.&NA;, pp.644-57, 2004.
DOI : 10.1097/01.sla.0000141198.92114.f6

C. Tournigand, T. André, E. Achille, G. Lledo, M. Flesh et al., FOLFIRI Followed by FOLFOX6 or the Reverse Sequence in Advanced Colorectal Cancer: A Randomized GERCOR Study, Journal of Clinical Oncology, vol.22, issue.2, pp.229-266, 2004.
DOI : 10.1200/JCO.2004.05.113

M. Buyse, Meta-Analysis Group in Cancer: Reappraisal of Hepatic Arterial Infusion in the Treatment of Non Resectable Liver Metastases from Colorectal Cancer, p.7269, 1942.

D. Elias, J. Ouellet, P. Thierry-de-baère, A. Lasser, and . Roche, Preoperative selective portal vein embolization before hepatectomy for liver metastases: Long-term results and impact on survival, Surgery, vol.131, issue.3, pp.294-99, 2002.
DOI : 10.1067/msy.2002.120234

A. M. Covey, T. Karen, W. R. Brown, L. A. Jarnagin, L. Brody et al., Combined Portal Vein Embolization and Neoadjuvant Chemotherapy As a Treatment Strategy for Resectable Hepatic Colorectal Metastases, Annals of Surgery, vol.247, issue.3, pp.451-55, 2008.
DOI : 10.1097/SLA.0b013e31815ed693

B. Aussilhou, S. Dokmak, S. Faivre, V. Paradis, V. Vilgrain et al., Preoperative Liver Hypertrophy Induced by Portal Flow Occlusion Before Major Hepatic Resection for Colorectal Metastases Can Be Impaired by Bevacizumab, Annals of Surgical Oncology, vol.25, issue.6, pp.1553-59, 2009.
DOI : 10.1097/01.sla.0000145964.08365.01

T. De-baere, J. M. Robinson, F. Deschamps, P. Rao, C. Teriitheau et al., Preoperative Portal Vein Embolization Tailored to Prepare the Liver for Complex Resections: Initial Experience, CardioVascular and Interventional Radiology, vol.176, issue.2, pp.976-82, 2010.
DOI : 10.2214/ajr.176.2.1760483

Y. Pang and . Yuk, The Brisbane, Terminology of Liver Anatomy and Resections. HPB HPB: The Official Journal of the International Hepato Pancreato Biliary Association, vol.2, issue.4 2, pp.333-372, 1080.

D. Zorzi, J. T. Mullen, E. K. Abdalla, T. M. Pawlik, A. Andres et al., Comparison Between Hepatic Wedge Resection and Anatomic Resection for Colorectal Liver Metastases, Journal of Gastrointestinal Surgery, vol.10, issue.1, pp.86-94, 2006.
DOI : 10.1016/j.gassur.2005.07.022

J. Machi, H. Isomoto, T. Kurohiji, Y. Yamashita, K. Shirouzu et al., Accuracy of intraoperative ultrasonography in diagnosing liver metastasis from colorectal cancer: Evaluation with postoperative follow-up results, World Journal of Surgery, vol.152, issue.4, pp.551-5610, 1991.
DOI : 10.1148/radiology.156.2.2989974

S. Fujita, T. Akasu, and Y. Moriya, Resection of Synchronous Liver Metastases from Colorectal Cancer, Japanese Journal of Clinical Oncology, vol.30, issue.1, pp.7-11, 2000.
DOI : 10.1093/jjco/hyd002

K. Tanaka, H. Shimada, K. Matsuo, Y. Nagano, I. Endo et al., Outcome after simultaneous colorectal and hepatic resection for colorectal cancer with synchronous metastases, Surgery, vol.136, issue.3, pp.650-59, 2004.
DOI : 10.1016/j.surg.2004.02.012

R. Martin, P. Paty, Y. Fong, A. Grace, A. Cohen et al., Simultaneous liver and colorectal resections are safe for synchronous colorectal liver metastasis, Journal of the American College of Surgeons, vol.197, issue.2, pp.233-274, 2003.
DOI : 10.1016/S1072-7515(03)00390-9

Y. Fong, J. Fortner, R. L. Sun, M. F. Brennan, and L. H. Blumgart, Clinical Score for Predicting Recurrence After Hepatic Resection for Metastatic Colorectal Cancer, Annals of Surgery, vol.230, issue.3, pp.309-327, 1999.
DOI : 10.1097/00000658-199909000-00004

R. Adam, E. Avisar, A. Ariche, S. Giachetti, D. Azoulay et al., Five-Year Survival Following Hepatic Resection After Neoadjuvant Therapy for Nonresectable Colorectal [Liver] Metastases, Annals of Surgical Oncology, vol.66, issue.4, pp.347-53, 2001.
DOI : 10.1007/s10434-001-0347-3

G. Ercolani, G. Grazi, M. Ravaioli, M. Cescon, A. Gardini et al., Liver Resection for Multiple Colorectal Metastases, Archives of Surgery, vol.137, issue.10, pp.1187-1192, 2002.
DOI : 10.1001/archsurg.137.10.1187

D. Jaeck and P. Pessaux, Bilobar Colorectal Liver Metastases: Treatment Options, Surgical Oncology Clinics of North America, vol.17, issue.3, pp.553-68, 2008.
DOI : 10.1016/j.soc.2008.02.006

S. Sharma, C. Camci, and N. Jabbour, Management of hepatic metastasis from colorectal cancers: an update, Journal of Hepato-Biliary-Pancreatic Surgery, vol.140, issue.6, pp.570-80, 2008.
DOI : 10.1067/msy.2001.112486

F. Bozzetti, . Doci, . Bignami, L. Morabito, and . Gennari, Patterns of Failure Following Surgical Resection of Colorectal Cancer Liver Metastases: Rationale for a Multimodal Approach, Annals of Surgery, vol.205, issue.3, pp.264-70, 1987.
DOI : 10.1007/978-3-642-83293-2_24

S. Benoist, A. Brouquet, C. Penna, C. Julié, S. Hajjam et al., Complete Response of Colorectal Liver Metastases After Chemotherapy: Does It Mean Cure?, Journal of Clinical Oncology, vol.24, issue.24, pp.3939-3984, 2006.
DOI : 10.1200/JCO.2006.05.8727

P. Pessaux, E. Lermite, O. Brehant, J. Tuech, G. Lorimier et al., Repeat hepatectomy for recurrent colorectal liver metastases, Journal of Surgical Oncology, vol.89, issue.1, pp.1-7, 2006.
DOI : 10.1002/jso.20384

R. Adam, G. Pascal, D. Azoulay, K. Tanaka, D. Castaing et al., Liver Resection for Colorectal Metastases, Annals of Surgery, vol.238, issue.6, pp.871-83, 2003.
DOI : 10.1097/01.sla.0000098112.04758.4e

E. K. Abdalla, R. Adam, A. J. Bilchik, D. Jaeck, J. Vauthey et al., Improving Resectability of Hepatic Colorectal Metastases: Expert Consensus Statement, Annals of Surgical Oncology, vol.12, issue.10, pp.1271-80, 2006.
DOI : 10.1007/BF02725339

M. A. Choti, V. James, M. F. Sitzmann, W. Tiburi, R. Sumetchotimetha et al., Trends in Long-Term Survival Following Liver Resection for Hepatic Colorectal Metastases, Annals of Surgery, vol.235, issue.6, pp.759-66, 2002.
DOI : 10.1097/00000658-200206000-00002

D. Cunningham, Y. Humblet, S. Siena, D. Khayat, H. Bleiberg et al., Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer, New England Journal of Medicine, vol.351, issue.4, pp.337-382, 2004.
DOI : 10.1056/NEJMoa033025

L. B. Saltz, J. V. Cox, C. Blanke, L. S. Rosen, L. Fehrenbacher et al., Irinotecan plus Fluorouracil and Leucovorin for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.343, issue.13, pp.905-1410, 2000.
DOI : 10.1056/NEJM200009283431302

M. J. Weiss and M. I. , Patient Selection for Hepatic Resection for Metastatic Colorectal Cancer, Journal of Gastrointestinal Oncology, vol.3, issue.1, 2012.

C. B. Wood, C. R. Gillis, and L. H. Blumgart, A Retrospective Study of the Natural History of Patients with Liver Metastases from Colorectal Cancer, Clinical Oncology, vol.2, issue.3, pp.285-88, 1976.

G. Steele, R. Bleday, R. J. Mayer, A. Lindblad, N. Petrelli et al., A prospective evaluation of hepatic resection for colorectal carcinoma metastases to the liver: Gastrointestinal Tumor Study Group Protocol 6584., Journal of Clinical Oncology, vol.9, issue.7, pp.1105-1117, 1991.
DOI : 10.1200/JCO.1991.9.7.1105

M. A. Adson, J. A. Van-heerden, M. H. Adson, J. S. Wagner, and D. M. Ilstrup, Resection of Hepatic Metastases From Colorectal Cancer, Archives of Surgery, vol.119, issue.6, pp.647-51, 1960.
DOI : 10.1001/archsurg.1984.01390180015003

P. Abitabile, U. Hartl, J. Lange, and C. A. Maurer, Radiofrequency ablation permits an effective treatment for colorectal liver metastasis, European Journal of Surgical Oncology (EJSO), vol.33, issue.1, pp.67-71, 2007.
DOI : 10.1016/j.ejso.2006.10.040

A. R. Gillams and W. R. Lees, Radio-frequency ablation of colorectal liver metastases in 167 patients, European Radiology, vol.15, issue.5, pp.2261-67, 2004.
DOI : 10.1148/radiology.196.1.7540310

A. A. Van-tilborg, M. R. Meijerink, C. Sietses, J. H. Van-waesberghe, M. O. Mackintosh et al., Long-term results of radiofrequency ablation for unresectable colorectal liver metastases: a potentially curative intervention, The British Journal of Radiology, vol.26, issue.1002, pp.556-65, 2011.
DOI : 10.1093/annonc/mdl029

S. A. Curley, P. Marra, K. Beaty, L. M. Ellis, J. N. Vauthey et al., Early and Late Complications After Radiofrequency Ablation of Malignant Liver Tumors in 608 Patients, Annals of Surgery, vol.239, issue.4, pp.450-58, 2004.
DOI : 10.1097/01.sla.0000118373.31781.f2

S. Mulier, P. Mulier, Y. Ni, Y. Miao, B. Dupas et al., Complications of radiofrequency coagulation of liver tumours, British Journal of Surgery, vol.217, issue.10, pp.1206-1228, 2002.
DOI : 10.1046/j.1365-2168.2002.02168.x

M. G. Lubner, L. Christopher, J. L. Brace, F. T. Hinshaw, and . Lee, Microwave Tumor Ablation: Mechanism of Action, Clinical Results, and Devices, Journal of Vascular and Interventional Radiology, vol.21, issue.8, pp.192-203, 2010.
DOI : 10.1016/j.jvir.2010.04.007

R. T. Groeschl, H. C. Charles, E. M. Pilgrim, K. A. Hanna, R. Z. Simo et al., Microwave Ablation for Hepatic Malignancies, Annals of Surgery, vol.259, issue.6, pp.1195-1200, 2014.
DOI : 10.1097/SLA.0000000000000234

E. Lahat, R. Eshkenazy, A. Zendel, M. Barak-bar-zakai, Y. Maor et al., Complications after Percutaneous Ablation of Liver Tumors: A Systematic Review, Hepatobiliary Surgery and Nutrition, vol.3, issue.5, pp.317-340, 2014.

P. J. Littrup, D. Hussein, B. Aoun, M. Adam, M. Krycia et al., Percutaneous cryoablation of hepatic tumors: long-term experience of a large U.S. series, Abdominal Radiology, vol.20, issue.176???181, pp.767-80, 2016.
DOI : 10.1016/j.rpor.2014.10.002

M. T. Silk, T. Wimmer, K. S. Lee, G. Srimathveeravalli, K. T. Brown et al., Percutaneous Ablation of Peribiliary Tumors with Irreversible Electroporation, Journal of Vascular and Interventional Radiology, vol.25, issue.1, pp.112-130, 2014.
DOI : 10.1016/j.jvir.2013.10.012

W. D. Ensminger, A. Rosowsky, V. Raso, D. C. Levin, M. Glode et al., A Clinical-Pharmacological Evaluation of Hepatic Arterial Infusions of 5-Fluoro-2?-Deoxyuridine and 5-Fluorouracil, Cancer Research, vol.38, issue.11 1, pp.3784-92, 1978.

S. Mocellin, S. Pasquali, and D. Nitti, Fluoropyrimidine-HAI (hepatic Arterial Infusion) versus Systemic Chemotherapy (SCT) for Unresectable Liver Metastases from Colorectal Cancer, The Cochrane Database of Systematic Reviews, issue.3, 2009.

D. Goéré, I. Deshaies, V. Thierry-de-baere, D. Boige, F. Malka et al., Prolonged Survival of Initially Unresectable Hepatic Colorectal Cancer Patients Treated With Hepatic Arterial Infusion of Oxaliplatin Followed by Radical Surgery of Metastases, Annals of Surgery, vol.251, issue.4, pp.686-91, 2010.
DOI : 10.1097/SLA.0b013e3181d35983

G. Farouil, F. Deschamps, A. Barah, A. Auperin, D. Goere et al., Interventional revisions of malfunctions affecting surgically implanted port-catheters for hepatic artery infusion, Surgical Oncology, vol.22, issue.1, pp.48-54, 2013.
DOI : 10.1016/j.suronc.2012.10.002

F. Deschamps, P. Rao, C. Teriitehau, A. Hakime, D. Malka et al., Percutaneous Femoral Implantation of an Arterial Port Catheter for Intraarterial Chemotherapy: Feasibility and Predictive Factors of Long-term Functionality, Journal of Vascular and Interventional Radiology, vol.21, issue.11, pp.1681-88, 2010.
DOI : 10.1016/j.jvir.2010.08.003

F. Deschamps, D. Elias, D. Goere, D. Malka, M. Ducreux et al., Intra-Arterial Hepatic Chemotherapy: A Comparison of Percutaneous Versus Surgical Implantation of Port-Catheters, CardioVascular and Interventional Radiology, vol.27, issue.4, pp.973-79, 2011.
DOI : 10.1097/01.COC.0000071465.29907.A5

K. Cardona, D. Donataccio, T. Peter-kingham, P. J. Allen, R. P. Dematteo et al., Treatment of Extensive Metastatic Colorectal Cancer to the Liver with Systemic and Hepatic Arterial Infusion Chemotherapy and Two-Stage Hepatic Resection: The Role of Salvage Therapy for Recurrent Disease, Annals of Surgical Oncology, vol.21, issue.3, pp.815-836, 2014.
DOI : 10.1002/(SICI)1097-0142(19960401)77:7<1254::AID-CNCR5>3.3.CO;2-R

V. Boige, D. Malka, D. Elias, M. Castaing, D. Thierry-de-baere et al., Hepatic Arterial Infusion of Oxaliplatin and Intravenous LV5FU2 in Unresectable Liver Metastases from Colorectal Cancer after Systemic Chemotherapy Failure, Annals of Surgical Oncology, vol.49, issue.1, pp.219-245, 2008.
DOI : 10.1245/s10434-007-9581-7

P. Rougier, A. Laplanche, M. Huguier, J. M. Hay, J. M. Ollivier et al., Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial., Journal of Clinical Oncology, vol.10, issue.7, pp.1112-1130, 1992.
DOI : 10.1200/JCO.1992.10.7.1112

M. Ducreux, M. Ychou, A. Laplanche, E. Gamelin, P. Lasser et al., Hepatic Arterial Oxaliplatin Infusion Plus Intravenous Chemotherapy in Colorectal Cancer With Inoperable Hepatic Metastases: A Trial of the Gastrointestinal Group of the F??d??ration Nationale des Centres de Lutte Contre le Cancer, Journal of Clinical Oncology, vol.23, issue.22, pp.4881-87, 2005.
DOI : 10.1200/JCO.2005.05.120

R. Salem and R. J. Lewandowski, Chemoembolization and Radioembolization for Hepatocellular Carcinoma Clinical Gastroenterology and Hepatology : The Official Clinical Practice, Journal of the American Gastroenterological Association, vol.11, issue.6, pp.604-648, 2013.

D. A. Leung, J. E. Goin, C. Sickles, B. J. Raskay, and M. C. Soulen, Determinants of Postembolization Syndrome after Hepatic Chemoembolization, Journal of Vascular and Interventional Radiology, vol.12, issue.3, pp.321-347, 2001.
DOI : 10.1016/S1051-0443(07)61911-3

D. Kessel and I. Robertson, Interventional Radiology: A Survival Guide Accessed, 2016.

G. Boily, J. Villeneuve, L. Lacoursière, P. Chaudhury, F. Couture et al., Transarterial embolization therapies for the treatment of hepatocellular carcinoma: CEPO review and clinical recommendations, HPB, vol.17, issue.1, pp.52-65, 2015.
DOI : 10.1111/hpb.12273

A. Sag, F. Alper, N. M. Selcukbiricik, and . Mandel, Evidence-based medical oncology and interventional radiology paradigms for liver-dominant colorectal cancer metastases, World Journal of Gastroenterology, vol.22, issue.11, pp.3127-3176, 2016.
DOI : 10.1186/1471-2407-14-497

J. P. Erinjeri, M. Husam, A. M. Salhab, G. I. Covey, K. T. Getrajdman et al., Arterial Patency after Repeated Hepatic Artery Bland Particle Embolization, Journal of Vascular and Interventional Radiology, vol.21, issue.4, pp.522-548, 2010.
DOI : 10.1016/j.jvir.2009.12.390

T. Tanaka, H. Nishiofuku, S. Maeda, T. Masada, H. Anai et al., Repeated Bland-TAE Using Small Microspheres Injected via an Implantable Port???Catheter System for Liver Metastases: An Initial Experience, CardioVascular and Interventional Radiology, vol.56, issue.2, pp.493-97, 2014.
DOI : 10.1016/j.jhep.2011.09.012

T. Tanaka, P. Isfort, T. Braunschweig, S. Westphal, A. Woitok et al., Superselective Particle Embolization Enhances Efficacy of Radiofrequency Ablation: Effects of Particle Size and Sequence of Action, CardioVascular and Interventional Radiology, vol.17, issue.3, pp.773-82, 2013.
DOI : 10.1097/01.RVI.0000228416.21560.7F

C. Lo, H. Ngan, W. Tso, C. Liu, C. Lam et al., Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma, Hepatology, vol.12, issue.5, pp.1164-71, 2002.
DOI : 10.1053/jhep.2002.33156

J. B. Kruskal, L. Hlatky, P. Hahnfeldt, K. Teramoto, K. R. Stokes et al., In Vivo and in Vitro Analysis of the Effectiveness of Doxorubicin Combined with Temporary Arterial Occlusion in Liver Tumors, Journal of Vascular and Interventional Radiology, vol.4, issue.6, pp.741-788, 1993.
DOI : 10.1016/S1051-0443(93)71965-X

E. K. Lang and C. L. Brown, Colorectal metastases to the liver: selective chemoembolization., Radiology, vol.189, issue.2, pp.417-439, 1993.
DOI : 10.1148/radiology.189.2.8210369

K. Hong, J. D. Mcbride, C. S. Georgiades, D. K. Reyes, J. M. Herman et al., Salvage Therapy for Liver-dominant Colorectal Metastatic Adenocarcinoma: Comparison between Transcatheter Arterial Chemoembolization versus Yttrium-90 Radioembolization, Journal of Vascular and Interventional Radiology, vol.20, issue.3, pp.360-67, 2009.
DOI : 10.1016/j.jvir.2008.11.019

T. J. Vogl, T. Gruber, J. O. Balzer, K. Eichler, R. Hammerstingl et al., Repeated Transarterial Chemoembolization in the Treatment of Liver Metastases of Colorectal Cancer: Prospective Study, Radiology, vol.250, issue.1, pp.281-89, 2009.
DOI : 10.1148/radiol.2501080295

S. W. Tuite, J. I. Stavropoulos, M. C. Mondschein, and . Soulen, Chemoembolization of Colorectal Liver Metastases with Cisplatin, Doxorubicin, Mitomycin C, Ethiodol, and Polyvinyl Alcohol, Cancer, vol.117, issue.2, pp.343-52, 2011.

R. C. Martin, R. Charles, D. Scoggins, M. Tomalty, T. Schreeder et al., Irinotecan Drug-Eluting Beads in the Treatment of Chemo-Naive Unresectable Colorectal Liver Metastasis with Concomitant Systemic Fluorouracil and Oxaliplatin: Results of Pharmacokinetics and Phase I Trial, Journal of Gastrointestinal Surgery, vol.26, issue.8, pp.1531-1569, 2012.
DOI : 10.1200/jco.2008.26.15_suppl.14608

P. P. Rao, F. Pascale, A. Seck, A. Auperin, L. Drouard-troalen et al., Irinotecan Loaded in Eluting Beads: Preclinical Assessment in a Rabbit VX2 Liver Tumor Model, CardioVascular and Interventional Radiology, vol.12, issue.1, pp.1448-59, 2012.
DOI : 10.1111/j.1477-2574.2009.00117.x

A. L. Lewis, M. V. Gonzalez, A. W. Lloyd, B. Hall, Y. Tang et al., DC Bead: In Vitro Characterization of a Drug-delivery Device for Transarterial Chemoembolization, Journal of Vascular and Interventional Radiology, vol.17, issue.2, pp.335-377, 2006.
DOI : 10.1097/01.RVI.0000195323.46152.B3

J. Namur, S. J. Citron, M. T. Sellers, M. H. Dupuis, M. Wassef et al., Embolization of hepatocellular carcinoma with drug-eluting beads: Doxorubicin tissue concentration and distribution in patient liver explants, Journal of Hepatology, vol.55, issue.6, pp.1332-1370, 2011.
DOI : 10.1016/j.jhep.2011.03.024

T. J. Vogl, S. Zangos, K. Eichler, D. Yakoub, and M. Nabil, Colorectal liver metastases: regional chemotherapy via transarterial chemoembolization (TACE) and hepatic chemoperfusion: an update, European Radiology, vol.25, issue.2, pp.1025-1059, 2007.
DOI : 10.2214/ajr.172.3.10063851

E. Liapi, J. , and H. Geschwind, Transcatheter and Ablative Therapeutic Approaches for Solid Malignancies, Journal of Clinical Oncology, vol.25, issue.8, pp.978-86, 2007.
DOI : 10.1200/JCO.2006.09.8657

R. C. Martin, J. Joshi, K. Robbins, D. Tomalty, R. O. Hara et al., Transarterial Chemoembolization of Metastatic Colorectal Carcinoma with Drug-Eluting Beads, Irinotecan (DEBIRI): Multi-Institutional Registry, Journal of Oncology, vol.215, issue.1, pp.539795-539805, 2009.
DOI : 10.1016/j.ejps.2006.09.002

R. Iezzi, V. A. Marsico, A. Guerra, E. Cerchiaro, A. Cassano et al., Trans-Arterial Chemoembolization with Irinotecan-Loaded Drug-Eluting Beads (DEBIRI) and Capecitabine in Refractory Liver Prevalent Colorectal Metastases: A Phase II Single-Center Study, CardioVascular and Interventional Radiology, vol.20, issue.6, pp.1523-1554, 2015.
DOI : 10.1016/j.jvir.2008.11.019

A. Kennedy, S. Nag, R. Salem, R. Murthy, A. J. Mcewan et al., Recommendations for Radioembolization of Hepatic Malignancies Using Yttrium-90 Microsphere Brachytherapy: A Consensus Panel Report from the Radioembolization Brachytherapy Oncology Consortium, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.1, pp.13-23, 2007.
DOI : 10.1016/j.ijrobp.2006.11.060

O. Pellerin and J. Geschwind, Traitement intra-art??riel des m??tastases h??patiques de cancer colorectal, Journal de Radiologie, vol.92, issue.9, pp.835-876, 2011.
DOI : 10.1016/j.jradio.2011.07.008

W. Y. Lau, S. Ho, T. W. Leung, M. Chan, R. Ho et al., Selective internal radiation therapy for nonresectable hepatocellular carcinoma with intraarterial infusion of 90yttrium microspheres, International Journal of Radiation Oncology*Biology*Physics, vol.40, issue.3, pp.583-92, 1998.
DOI : 10.1016/S0360-3016(97)00818-3

R. Salem and R. J. Lewandowski, Chemoembolization and Radioembolization for Hepatocellular Carcinoma Clinical Gastroenterology and Hepatology : The Official Clinical Practice, Journal of the American Gastroenterological Association, vol.11, issue.6, pp.604-648, 2013.

J. Young, T. Rhee, B. Atassi, V. Gates, L. Kulik et al., Radiation Dose Limits and Liver Toxicities Resulting from Multiple Yttrium-90 Radioembolization Treatments for Hepatocellular Carcinoma, Journal of Vascular and Interventional Radiology, vol.18, issue.11, pp.1375-82, 2007.
DOI : 10.1016/j.jvir.2007.07.016

J. E. Dancey, F. A. Shepherd, K. Paul, K. W. Sniderman, S. Houle et al., Treatment of Nonresectable Hepatocellular Carcinoma with Intrahepatic 90Y- Microspheres, Journal of Nuclear Medicine: Official Publication, Society of Nuclear Medicine, vol.41, issue.10, pp.1673-81, 2000.

S. J. Dutton, N. Kenealy, S. B. Love, H. S. Wasan, R. A. Sharma et al., FOXFIRE protocol: an open-label, randomised, phase III trial of 5-fluorouracil, oxaliplatin and folinic acid (OxMdG) with or without interventional Selective Internal Radiation Therapy (SIRT) as first-line treatment for patients with unresectable liver-only or liver-dominant metastatic colorectal cancer, BMC Cancer, vol.45, issue.2, pp.497-507, 2014.
DOI : 10.1016/j.ejca.2008.10.026

V. Hazel, A. Guy, J. Blackwell, D. Anderson, P. Price et al., Randomised phase 2 trial of SIR-Spheres?? plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancer, Journal of Surgical Oncology, vol.7, issue.Supp 2, pp.78-85, 2004.
DOI : 10.1023/A:1008200825886

A. A. Sag, A. Michael, N. R. Savin, R. R. Lal, and . Mehta, Yttrium-90 Radioembolization of Malignant Tumors of the Liver: Gallbladder Effects, American Journal of Roentgenology, vol.202, issue.5, pp.1130-1165, 2014.
DOI : 10.2214/AJR.13.10548

. Atassi, A. K. Bassel, R. J. Bangash, S. Lewandowski, L. Ibrahim et al., Biliary Sequelae following Radioembolization with Yttrium-90 Microspheres, Journal of Vascular and Interventional Radiology, vol.19, issue.5
DOI : 10.1016/j.jvir.2008.01.003

A. B. Benson, M. F. Jean-francois-geschwind, W. Mulcahy, G. Rilling, G. Siskin et al., Radioembolisation for liver metastases: Results from a prospective 151 patient multi-institutional phase II study, European Journal of Cancer, vol.49, issue.15, pp.3122-3152, 1990.
DOI : 10.1016/j.ejca.2013.05.012

C. T. Sofocleous, A. R. Garcia, N. Pandit-taskar, K. G. Do, L. A. Brody et al., Phase I Trial of Selective Internal Radiation Therapy for Chemorefractory Colorectal Cancer Liver Metastases Progressing After Hepatic Arterial Pump and Systemic Chemotherapy, Clinical Colorectal Cancer, vol.13, issue.1, pp.27-36, 2014.
DOI : 10.1016/j.clcc.2013.11.010

B. Gray, G. Van-hazel, M. Hope, M. Burton, P. Moroz et al., Randomised trial of SIR-Spheres?? plus chemotherapy vs. chemotherapy alone for treating patients with liver metastases from primary large bowel cancer, Annals of Oncology, vol.12, issue.12, pp.1711-1731, 2001.
DOI : 10.1023/A:1013569329846

A. Hendlisz, M. Van-den-eynde, M. Peeters, G. Maleux, B. Lambert et al., Phase III Trial Comparing Protracted Intravenous Fluorouracil Infusion Alone or With Yttrium-90 Resin Microspheres Radioembolization for Liver-Limited Metastatic Colorectal Cancer Refractory to Standard Chemotherapy, Journal of Clinical Oncology, vol.28, issue.23, pp.3687-94, 2010.
DOI : 10.1200/JCO.2010.28.5643

B. Sangro, M. Iñarrairaegui, and A. S. Kennedy, Radioembolization-Induced Liver Disease, Liver Radioembolization with 90Y Microspheres, pp.177-85, 1007.
DOI : 10.1007/174_2013_817

S. Swiss, G. For-clinical-cancer, and . Research, Long-Term Results of Single Course of Adjuvant Intraportal Chemotherapy for Colorectal Cancer, The Lancet, vol.345, issue.8946, pp.349-53, 1995.

U. Laffer, U. Metzger, P. Aeberhard, M. Lorenz, F. Harder et al., EBSCOhost | 35276937 | Adjuvant Perioperative Portal Vein or Peripheral Intravenous Chemotherapy for Potentially Curative Colorectal Cancer: Long-Term Results of a Randomized Controlled Trial, International Journal of Colorectal Disease, 2016.

Y. Fong, T. Kim, A. Bhargava, L. Schwartz, K. Brown et al., A Herpes Oncolytic Virus Can Be Delivered Via the Vasculature to Produce Biologic Changes in Human Colorectal Cancer, Molecular Therapy, vol.17, issue.2, pp.389-94, 2009.
DOI : 10.1038/mt.2008.240

A. D. Colevas and A. Setser, The NCI Common Terminology Criteria for Adverse Events (CTCAE) v 3.0 Is the New Standard for Oncology Clinical Trials, ASCO Meeting Abstracts, vol.22, issue.14_suppl, p.6098, 2004.

A. Sjövall, V. Järv, L. Blomqvist, T. Singnomklao, B. Cedermark et al., The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study, European Journal of Surgical Oncology (EJSO), vol.30, issue.8, pp.834-875, 2004.
DOI : 10.1016/j.ejso.2004.06.010

C. R. Scoggins, L. Michael, C. S. Campbell, B. A. Landry, C. E. Slomiany et al., Preoperative Chemotherapy Does Not Increase Morbidity or Mortality of Hepatic Resection for Colorectal Cancer Metastases, Annals of Surgical Oncology, vol.90, issue.1, pp.35-41, 2009.
DOI : 10.1002/bjs.4160

E. K. Abdalla, J. Vauthey, L. M. Ellis, V. Ellis, R. Pollock et al., Recurrence and Outcomes Following Hepatic Resection, Radiofrequency Ablation, and Combined Resection/Ablation for Colorectal Liver Metastases, Annals of Surgery, vol.239, issue.6, pp.818-843, 2004.
DOI : 10.1097/01.sla.0000128305.90650.71

M. M. Borner, M. Castiglione, M. Bacchi, W. Weber, R. Herrmann et al., The Impact of Adding Low-Dose Leucovorin to Monthly 5-Fluorouracil in Advanced Colorectal Carcinoma: Results of a Phase III Trial, Annals of Oncology, vol.9, issue.5, pp.535-576, 1998.
DOI : 10.1023/A:1008270916325

R. M. Goldberg, J. Daniel, R. F. Sargent, C. S. Morton, R. K. Fuchs et al., A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer, Journal of Clinical Oncology, vol.22, issue.1, pp.23-30, 2004.
DOI : 10.1200/JCO.2004.09.046

. Van-cutsem, C. Eric, E. Köhne, J. Hitre, C. Zaluski et al., Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer, New England Journal of Medicine, vol.360, issue.14, pp.1408-1710, 2009.
DOI : 10.1056/NEJMoa0805019

J. M. Cleary, T. Kenneth, G. Y. Tanabe, A. X. Lauwers, and . Zhu, Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver, The Oncologist, vol.14, issue.11, pp.1095-1105, 2009.
DOI : 10.1634/theoncologist.2009-0152

A. P. Stillwell, Y. Ho, and C. Veitch, Systematic Review of Prognostic Factors Related to Overall Survival in Patients with Stage IV Colorectal Cancer and Unresectable Metastases, World Journal of Surgery, vol.5, issue.9, pp.684-92, 2011.
DOI : 10.1097/00000421-198212000-00014

B. Guiu, F. Deschamps, S. Aho, F. Munck, C. Dromain et al., Liver/biliary injuries following chemoembolisation of endocrine tumours and hepatocellular carcinoma: Lipiodol vs. drug-eluting beads, Journal of Hepatology, vol.56, issue.3, pp.609-626, 2012.
DOI : 10.1016/j.jhep.2011.09.012